Abstract
Rare monogenetic diseases provide a unique window into the basic understanding of the resulting pathology. In a complex organ system such at the vasculature, identification of rare diseases that affect the architecture and/or cellular makeup of the vessel provides further insight into the underlying mechanisms that regulate homeostasis in healthy tissue.
More than just conduits for the movement of blood throughout the body, arteries contribute to the greater cardiovascular and general health of an individual via their ability to regulate blood pressure and heart rate. The wall of an artery consists of three layers: the tunica adventitia is the outer sheath which consists of fibroblasts, pericytes, and various resident immune cells, connective tissue, and collagen and elastic fibers; the tunica media, a thicker middle layer consisting of vascular smooth muscle cells, an abundant layer extracellular matrix, and elastic fibers; and the inner tunica intima, an elastic membrane upon which endothelial cells reside and have direct contact with blood. Below is a summary of monogenetic diseases that manifest the most common deleterious alterations in the vascular wall: atherosclerosis, aneurysms, and stiffening of the arteries. We have grouped these diseases by the general molecular mechanisms that are altered as a result of the identified genetic mutations. We believe that looking at disease pathologies through a molecular lens helps to understand the common mechanisms underlying vessel homeostasis and is beneficial for identifying potential therapeutic targets and treatment strategies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- Aneurysm:
-
A weakening in the wall of an artery resulting in vessel enlargement.
- Angiotensin-converting enzyme (ACE) inhibitors:
-
A class of drugs used to treat hypertension and congestive heart failure.
- Aortic dilation:
-
Widening of the luminal diameter of the aorta.
- Aortic dissection:
-
Tearing of the inner wall of the aorta allowing blood to flow between the vessel wall layers forcing the layers to separate.
- Apolipoprotein:
-
Proteins that bind to lipids to form lipoproteins.
- Arterial calcification:
-
Calcification of the arteries. May be located in the medial or the intima of the vessel.
- Arteriovenous malformation:
-
Abnormal direct connection between arteries and veins that circumvents the capillary system.
- Beta-blocker:
-
A class of drugs used to control cardiac arrhythmia, treat angina, and reduce high blood pressure.
- Bicuspid aortic valve:
-
Congenital condition whereby two of the three aortic valvular leaflets fuse, creating a bicuspid valve instead of a tricuspid valve.
- Bisphosphonates:
-
A class of drugs that mimic the structure of pyrophosphate, are used to treat bone loss, and have shown in some cases to prevent and even reverse vascular calcification.
- Chylomicrons:
-
Lipoprotein particles that transport dietary lipids from the intestines to the rest of the body.
- Dyslipidemia:
-
An abnormal amount of lipids (cholesterol and/or fat) in the blood.
- Genetic locus:
-
The chromosomal location of a gene or DNA sequence.
- HMG-CoA reductase:
-
3-hydroxy-3-methylglutaryl-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis; converts HMG-CoA to mevalonic acid.
- Hydroxyapatite:
-
Mineral that is the main component of tooth enamel and bone and found in vascular calcification.
- Hypertriglyceridemia:
-
High blood levels of triglycerides.
- Lipoprotein:
-
Includes very-low-density lipoprotein (VLDL), low-density lipoprotein (LDL), intermediate-density lipoprotein (IDL), and high-density lipoprotein (HDL). These are soluble spherical particles made up of proteins and lipids that transport fats and cholesterol throughout the blood plasma.
- Patent ductus arteriosus (PDA):
-
Congenital heart defect where the neonatal ductus arteriosus does not properly seal shut after birth.
- Regurgitation, aortic and mitral:
-
The leaking of the aortic or mitral valves of the heart results in aberrant blood flow.
- Statins:
-
A type of pharmaceutical drug that lowers cholesterol biosynthesis by inhibition of HMG-CoA reductase.
- Telangiectasias:
-
Small dilated blood vessels at or near the surface of the skin or mucous membranes.
- Whole-exome sequencing (WES):
-
The sequencing of the parts of the genome encode for genes.
- Xanthomas:
-
Discolored patches on the skin consisting of lipid deposits.
References
Abdalla SA, Letarte M (2006) Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease. J Med Genet 43(2):97–110. doi:10.1136/jmg.2005.030833
Allison MA, Criqui MH, Wright CM (2004) Patterns and risk factors for systemic calcified atherosclerosis. Arterioscler Thromb Vasc Biol 24(2):331–336. doi:10.1161/01.ATV.0000110786.02097.0c
Arthur HM, Ure J, Smith AJ et al (2000) Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development. Dev Biol 217(1):42–53. doi:10.1006/dbio.1999.9534
Atkinson C, Stewart S, Upton PD et al (2002) Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor. Circulation 105(14):1672–1678
Attisano L, Carcamo J, Ventura F et al (1993) Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors. Cell 75(4):671–680
Azoulay M, Henry I, Tata F et al (1987) The structural gene for lecithin: cholesterol acyl transferase (LCAT) maps to 16q22. Ann Hum Genet 51(Pt 2):129–136
Barst RJ, Rubin LJ, Long WA et al (1996) A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med 334(5):296–301. doi:10.1056/NEJM199602013340504
Bateson EA, Schulz R, Olley PM (1999) Response of fetal rabbit ductus arteriosus to bradykinin: role of nitric oxide, prostaglandins, and bradykinin receptors. Pediatr Res 45(4 Pt 1):568–574. doi:10.1203/00006450-199904010-00017
Bayrak-Toydemir P, McDonald J, Akarsu N et al (2006) A fourth locus for hereditary hemorrhagic telangiectasia maps to chromosome 7. Am J Med Genet A 140(20):2155–2162. doi:10.1002/ajmg.a.31450
Berge KE, Tian H, Graf GA et al (2000) Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 290(5497):1771–1775
Bergen AA, Plomp AS, Schuurman EJ et al (2000) Mutations in ABCC6 cause pseudoxanthoma elasticum. Nat Genet 25(2):228–231. doi:10.1038/76109
Betteridge DJ, Krone W, Reckless JP et al (1978) Compactin inhibits cholesterol synthesis in lymphocytes and intestinal mucosa from patients with familial hypercholesterolaemia. Lancet 2(8104–5):1342–1343
Bhattacharyya AK, Connor WE (1974) Beta-sitosterolemia and xanthomatosis. A newly described lipid storage disease in two sisters. J Clin Invest 53(4):1033–1043. doi:10.1172/JCI107640
Block SM (1996) Fifty ways to love your lever: myosin motors. Cell 87(2):151–157
Bodzioch M, Orso E, Klucken J et al (1999) The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet 22(4):347–351. doi:10.1038/11914
Bottger P, Hede SE, Grunnet M et al (2006) Characterization of transport mechanisms and determinants critical for Na + −dependent Pi symport of the PiT family paralogs human PiT1 and PiT2. Am J Physiol Cell Physiol 291(6):C1377–C1387. doi:10.1152/ajpcell.00015.2006
Bourdeau A, Dumont DJ, Letarte M (1999) A murine model of hereditary hemorrhagic telangiectasia. J Clin Invest 104(10):1343–1351. doi:10.1172/JCI8088
Braun JE, Severson DL (1992) Regulation of the synthesis, processing and translocation of lipoprotein lipase. Biochem J 287(Pt 2):337–347
Breckenridge WC, Little JA, Steiner G et al (1978) Hypertriglyceridemia associated with deficiency of apolipoprotein C-II. N Engl J Med 298(23):1265–1273. doi:10.1056/NEJM197806082982301
Brooks-Wilson A, Marcil M, Clee SM et al (1999) Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet 22(4):336–345. doi:10.1038/11905
Brown MS, Goldstein JL (1976) Analysis of a mutant strain of human fibroblasts with a defect in the internalization of receptor-bound low density lipoprotein. Cell 9(4 PT 2):663–674
Bryant J, White W (1901) A case of calcification of the arteries and obliterative endarteritis, associated with hydronephrosis, in a child aged six months. Guy’s Hosp Rep 55:17
Bunton TE, Biery NJ, Myers L et al (2001) Phenotypic alteration of vascular smooth muscle cells precedes elastolysis in a mouse model of Marfan syndrome. Circ Res 88(1):37–43
Cardoso S, Robertson SP, Daniel PB (2012) TGFBR1 mutations associated with Loeys-Dietz syndrome are inactivating. J Recept Signal Transduct Res 32(3):150–155. doi:10.3109/10799893.2012.664553
Carlson LA (1982) Fish eye disease: a new familial condition with massive corneal opacities and dyslipoproteinaemia. Eur J Clin Invest 12(1):41–53
Carlson LA, Philipson B (1979) Fish-eye disease. A new familial condition with massive corneal opacities and dyslipoproteinaemia. Lancet 2(8149):922–924
Castrop H, Huang Y, Hashimoto S et al (2004) Impairment of tubuloglomerular feedback regulation of GFR in ecto-5′-nucleotidase/CD73-deficient mice. J Clin Invest 114(5):634–642. doi:10.1172/JCI21851
Chassaing N, Martin L, Calvas P et al (2005) Pseudoxanthoma elasticum: a clinical, pathophysiological and genetic update including 11 novel ABCC6 mutations. J Med Genet 42(12):881–892. doi:10.1136/jmg.2004.030171
Chen SH, Habib G, Yang CY et al (1987) Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame stop codon. Science 238(4825):363–366
Cheng KS, Chen MR, Ruf N et al (2005) Generalized arterial calcification of infancy: different clinical courses in two affected siblings. Am J Med Genet A 136(2):210–213. doi:10.1002/ajmg.a.30800
Cholesterol Treatment Trialists C (2012) The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet 380(9841):581–590
Choudhary B, Zhou J, Li P et al (2009) Absence of TGFbeta signaling in embryonic vascular smooth muscle leads to reduced lysyl oxidase expression, impaired elastogenesis, and aneurysm. Genesis 47(2):115–121. doi:10.1002/dvg.20466
Cole SG, Begbie ME, Wallace GM et al (2005) A new locus for hereditary haemorrhagic telangiectasia (HHT3) maps to chromosome 5. J Med Genet 42(7):577–582. doi:10.1136/jmg.2004.028712
Cox DW, Wills DE, Quan F et al (1988) A deletion of one nucleotide results in functional deficiency of apolipoprotein CII (apo CII Toronto). J Med Genet 25(10):649–652
Crouthamel MH, Lau WL, Leaf EM et al (2013) Sodium-dependent phosphate cotransporters and phosphate-induced calcification of vascular smooth muscle cells: redundant roles for PiT-1 and PiT-2. Arterioscler Thromb Vasc Biol 33(11):2625–2632. doi:10.1161/ATVBAHA.113.302249
Dai X, Gao Y, Xu Z et al (2010) Identification of a novel genetic locus on chromosome 8p21.1-q11.23 for idiopathic basal ganglia calcification. Am J Med Genet B Neuropsychiatr Genet 153B(7):1305–1310. doi:10.1002/ajmg.b.31102
Dammerman M, Breslow JL (1995) Genetic basis of lipoprotein disorders. Circulation 91(2):505–512
Darier J (1896) Pseudoxanthoma elasticum. Monatshefte Prakt Derm 23:609–617
David L, Mallet C, Mazerbourg S et al (2007) Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells. Blood 109(5):1953–1961. doi:10.1182/blood-2006-07-034124
de Jesus Perez VA, Alastalo TP, Wu JC et al (2009) Bone morphogenetic protein 2 induces pulmonary angiogenesis via Wnt-beta-catenin and Wnt-RhoA-Rac1 pathways. J Cell Biol 184(1):83–99. doi:10.1083/jcb.200806049
Demer LL, Tintut Y (2008) Vascular calcification: pathobiology of a multifaceted disease. Circulation 117(22):2938–2948. doi:10.1161/CIRCULATIONAHA.107.743161
Deng Z, Morse JH, Slager SL et al (2000) Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. Am J Hum Genet 67(3):737–744. doi:10.1086/303059
Derynck R, Zhang YE (2003) Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425(6958):577–584. doi:10.1038/nature02006
Dietz HC, Cutting GR, Pyeritz RE et al (1991) Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 352(6333):337–339. doi:10.1038/352337a0
Dlamini N, Splitt M, Durkan A et al (2009) Generalized arterial calcification of infancy: phenotypic spectrum among three siblings including one case without obvious arterial calcifications. Am J Med Genet A 149A(3):456–460. doi:10.1002/ajmg.a.32646
Downing AK, Knott V, Werner JM et al (1996) Solution structure of a pair of calcium-binding epidermal growth factor-like domains: implications for the Marfan syndrome and other genetic disorders. Cell 85(4):597–605
Eldadah ZA, Brenn T, Furthmayr H et al (1995) Expression of a mutant human fibrillin allele upon a normal human or murine genetic background recapitulates a Marfan cellular phenotype. J Clin Invest 95(2):874–880. doi:10.1172/JCI117737
Erbel R, Alfonso F, Boileau C et al (2001) Diagnosis and management of aortic dissection: task force on aortic dissection, European Society of Cardiology. Eur Heart J 22(18):1642–1681. doi:10.1053/euhj.2001.2782
Farmer JA (1998) Aggressive lipid therapy in the statin era. Prog Cardiovasc Dis 41(2):71–94
Fatigati V, Murphy RA (1984) Actin and tropomyosin variants in smooth muscles. Dependence on tissue type. J Biol Chem 259(23):14383–14388
Festing MH, Speer MY, Yang HY et al (2009) Generation of mouse conditional and null alleles of the type III sodium-dependent phosphate cotransporter PiT-1. Genesis 47(12):858–863. doi:10.1002/dvg.20577
Fielding CJ, Fielding PE (1995) Molecular physiology of reverse cholesterol transport. J Lipid Res 36(2):211–228
Finger RP, Charbel Issa P, Ladewig MS et al (2009) Pseudoxanthoma elasticum: genetics, clinical manifestations and therapeutic approaches. Surv Ophthalmol 54(2):272–285. doi:10.1016/j.survophthal.2008.12.006
Fitzgerald ML, Morris AL, Rhee JS et al (2002) Naturally occurring mutations in the largest extracellular loops of ABCA1 can disrupt its direct interaction with apolipoprotein A-I. J Biol Chem 277(36):33178–33187. doi:10.1074/jbc.M204996200
Flatmark AL, Hovig T, Myhre E et al (1977) Renal transplantation in patients with familial lecithin: cholesterol-acetyltransferase deficiency. Transplant Proc 9(3):1665–1671
Fleisch H (1987) Bisphosphonates–history and experimental basis. Bone 8(Suppl 1):S23–S28
Fleisch H, Russell RG, Straumann F (1966) Effect of pyrophosphate on hydroxyapatite and its implications in calcium homeostasis. Nature 212(5065):901–903
Foley J (1951) Calcification of the corpus striatum and dentate nuclei occurring in a family. J Neurol Neurosurg Psychiatry 14(4):253–261
Francis GA, Knopp RH, Oram JF (1995) Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier disease. J Clin Invest 96(1):78–87. doi:10.1172/JCI118082
Francone OL, Gurakar A, Fielding C (1989) Distribution and functions of lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in plasma lipoproteins. Evidence for a functional unit containing these activities together with apolipoproteins A-I and D that catalyzes the esterification and transfer of cell-derived cholesterol. J Biol Chem 264(12):7066–7072
Fredrickson DS, Altrocchi PH, Avioli LV, Goodman DS, Goodman HC (1961) Tangier disease. Ann Intern Med 55:1016–1031
Frikke-Schmidt R, Nordestgaard BG, Jensen GB et al (2004) Genetic variation in ABC transporter A1 contributes to HDL cholesterol in the general population. J Clin Invest 114(9):1343–1353. doi:10.1172/JCI20361
Fuchizaki U, Miyamori H, Kitagawa S et al (2003) Hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease). Lancet 362(9394):1490–1494. doi:10.1016/S0140-6736(03)14696-X
Fung M, Hill J, Cook D et al (2011) Case series of type III hyperlipoproteinemia in children. BMJ Case Rep 2011. doi:10.1136/bcr.02.2011.3895
Furlong J, Kurczynski TW, Hennessy JR (1987) New Marfanoid syndrome with craniosynostosis. Am J Med Genet 26(3):599–604. doi:10.1002/ajmg.1320260314
Gahl WA, Tifft CJ (2011) The NIH undiagnosed diseases program: lessons learned. JAMA 305(18):1904–1905. doi:10.1001/jama.2011.613
Giachelli CM (2009) The emerging role of phosphate in vascular calcification. Kidney Int 75(9):890–897. doi:10.1038/ki.2008.644
Gjone E, Norum KR (1968) Familial serum cholesterol ester deficiency. Clinical study of a patient with a new syndrome. Acta Med Scand 183(1–2):107–112
Goldstein JL, Brown MS (1973) Familial hypercholesterolemia: identification of a defect in the regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity associated with overproduction of cholesterol. Proc Natl Acad Sci U S A 70(10):2804–2808
Golledge J, Muller J, Daugherty A et al (2006) Abdominal aortic aneurysm: pathogenesis and implications for management. Arterioscler Thromb Vasc Biol 26(12):2605–2613. doi:10.1161/01.ATV.0000245819.32762.cb
Goumans MJ, Valdimarsdottir G, Itoh S et al (2002) Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors. EMBO J 21(7):1743–1753. doi:10.1093/emboj/21.7.1743
Gregg RE, Zech LA, Schaefer EJ et al (1981) Type III hyperlipoproteinemia: defective metabolism of an abnormal apolipoprotein E. Science 211(4482):584–586
Groenink M, den Hartog AW, Franken R et al (2013) Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial. Eur Heart J. doi:10.1093/eurheartj/eht334
Guo D, Hasham S, Kuang SQ et al (2001) Familial thoracic aortic aneurysms and dissections: genetic heterogeneity with a major locus mapping to 5q13-14. Circulation 103(20):2461–2468
Guo DC, Pannu H, Tran-Fadulu V et al (2007) Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections. Nat Genet 39(12):1488–1493. doi:10.1038/ng.2007.6
Guo DC, Papke CL, Tran-Fadulu V et al (2009) Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and Moyamoya disease, along with thoracic aortic disease. Am J Hum Genet 84(5):617–627. doi:10.1016/j.ajhg.2009.04.007
Hansmann G, de Jesus Perez VA, Alastalo TP et al (2008) An antiproliferative BMP-2/PPARgamma/apoE axis in human and murine SMCs and its role in pulmonary hypertension. J Clin Invest 118(5):1846–1857. doi:10.1172/JCI32503
Hautmann MB, Madsen CS, Owens GK (1997) A transforming growth factor beta (TGFbeta) control element drives TGFbeta-induced stimulation of smooth muscle alpha-actin gene expression in concert with two CArG elements. J Biol Chem 272(16):10948–10956
Havel RJ, Gordon RS Jr (1960) Idiopathic hyperlipemia: metabolic studies in an affected family. J Clin Invest 39:1777–1790. doi:10.1172/JCI104202
Hobbs HH, Russell DW, Brown MS et al (1990) The LDL receptor locus in familial hypercholesterolemia: mutational analysis of a membrane protein. Annu Rev Genet 24:133–170. doi:10.1146/annurev.ge.24.120190.001025
Hoffman JI, Kaplan S (2002) The incidence of congenital heart disease. J Am Coll Cardiol 39(12):1890–1900
Hu X, Plomp A, Wijnholds J et al (2003) ABCC6/MRP6 mutations: further insight into the molecular pathology of pseudoxanthoma elasticum. Eur J Hum Genet 11(3):215–224. doi:10.1038/sj.ejhg.5200953
Hunt AC, Leys DG (1957) Generalized arterial calcification of infancy. Br Med J 1(5015):385–386
IMS_Institute (2012) The use of medicines in the United States: review of 2011. Parsippany
Isselbacher EM (2005) Thoracic and abdominal aortic aneurysms. Circulation 111(6):816–828. doi:10.1161/01.CIR.0000154569.08857.7A
Jansen RS, Kucukosmanoglu A, de Haas M et al (2013) ABCC6 prevents ectopic mineralization seen in pseudoxanthoma elasticum by inducing cellular nucleotide release. Proc Natl Acad Sci U S A. doi:10.1073/pnas.1319582110
Jiang Q, Endo M, Dibra F et al (2009) Pseudoxanthoma elasticum is a metabolic disease. J Invest Dermatol 129(2):348–354. doi:10.1038/jid.2008.212
Johnson DW, Berg JN, Gallione CJ et al (1995) A second locus for hereditary hemorrhagic telangiectasia maps to chromosome 12. Genome Res 5(1):21–28
Johnson DW, Berg JN, Baldwin MA et al (1996) Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet 13(2):189–195. doi:10.1038/ng0696-189
Jono S, McKee MD, Murry CE et al (2000) Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 87(7):E10–E17
Judge DP, Biery NJ, Keene DR et al (2004) Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome. J Clin Invest 114(2):172–181. doi:10.1172/JCI20641
Kainulainen K, Steinmann B, Collins F et al (1991) Marfan syndrome: no evidence for heterogeneity in different populations, and more precise mapping of the gene. Am J Hum Genet 49(3):662–667
Kakita A, Suzuki A, Nishiwaki K et al (2004) Stimulation of Na-dependent phosphate transport by platelet-derived growth factor in rat aortic smooth muscle cells. Atherosclerosis 174(1):17–24. doi:10.1016/j.atherosclerosis.2003.12.039
Kanthapillai P, Lasserson T, Walters E (2004) Sildenafil for pulmonary hypertension. Cochrane Database Syst Rev 4, CD003562. doi:10.1002/14651858.CD003562.pub2
Kavanaugh MP, Miller DG, Zhang W et al (1994) Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters. Proc Natl Acad Sci U S A 91(15):7071–7075
Khau Van Kien P, Wolf JE, Mathieu F et al (2004) Familial thoracic aortic aneurysm/dissection with patent ductus arteriosus: genetic arguments for a particular pathophysiological entity. Eur J Hum Genet 12(3):173–180. doi:10.1038/sj.ejhg.5201119
Kobayashi S, Yamadori I, Miki H et al (1987) Idiopathic nonarteriosclerotic cerebral calcification (Fahr’s disease): an electron microscopic study. Acta Neuropathol 73(1):62–66
Kool M, van der Linden M, de Haas M et al (1999) Expression of human MRP6, a homologue of the multidrug resistance protein gene MRP1, in tissues and cancer cells. Cancer Res 59(1):175–182
Kunnen S, Van Eck M (2012) Lecithin: cholesterol acyltransferase: old friend or foe in atherosclerosis? J Lipid Res 53(9):1783–1799. doi:10.1194/jlr.R024513
Lane KB, Machado RD, Pauciulo MW et al (2000) Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. Nat Genet 26(1):81–84. doi:10.1038/79226
Langlois S, Deeb S, Brunzell JD et al (1989) A major insertion accounts for a significant proportion of mutations underlying human lipoprotein lipase deficiency. Proc Natl Acad Sci USA 86(3):948–952
Langmann T, Klucken J, Reil M et al (1999) Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages. Biochem Biophys Res Commun 257(1):29–33. doi:10.1006/bbrc.1999.0406
Lasater EA, Bessler WK, Mead LE et al (2008) Nf1+/− mice have increased neointima formation via hyperactivation of a Gleevec sensitive molecular pathway. Human Mol Genet 17(15):2336–2344. doi:10.1093/hmg/ddn134
Lau PP, Zhu HJ, Baldini A et al (1994) Dimeric structure of a human apolipoprotein B mRNA editing protein and cloning and chromosomal localization of its gene. Proc Natl Acad Sci USA 91(18):8522–8526
Le Boulanger G, Labreze C, Croue A et al (2010) An unusual severe vascular case of pseudoxanthoma elasticum presenting as generalized arterial calcification of infancy. Am J Med Genet A 152A(1):118–123. doi:10.1002/ajmg.a.33162
Le Saux O, Urban Z, Tschuch C et al (2000) Mutations in a gene encoding an ABC transporter cause pseudoxanthoma elasticum. Nat Genet 25(2):223–227. doi:10.1038/76102
Le Saux O, Bunda S, VanWart CM et al (2006) Serum factors from pseudoxanthoma elasticum patients alter elastic fiber formation in vitro. J Invest Dermatol 126(7):1497–1505. doi:10.1038/sj.jid.5700201
Lee SD, Shroyer KR, Markham NE et al (1998) Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension. J Clin Invest 101(5):927–934. doi:10.1172/JCI1910
Li DY, Sorensen LK, Brooke BS et al (1999) Defective angiogenesis in mice lacking endoglin. Science 284(5419):1534–1537
Li X, Yang HY, Giachelli CM (2006) Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification. Circ Res 98(7):905–912. doi:10.1161/01.RES.0000216409.20863.e7
Lindahl P, Johansson BR, Leveen P et al (1997) Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 277(5323):242–245
Loeys BL, Chen JJ, Neptune ER et al (2005) A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet 37(3):275–281. doi:10.1038/Ng1511
Loeys BL, Schwarze U, Holm T et al (2006) Aneurysm syndromes caused by mutations in the TGF-beta receptor. New England J Med 355(8):788–798. doi:10.1056/Nejmoa055695
Lorenz-Depiereux B, Schnabel D, Tiosano D et al (2010) Loss-of-function ENPP1 mutations cause both generalized arterial calcification of infancy and autosomal-recessive hypophosphatemic rickets. Am J Hum Genet 86(2):267–272. doi:10.1016/j.ajhg.2010.01.006
Macchiaiolo M, Gagliardi MG, Toscano A et al (2012) Homozygous familial hypercholesterolaemia. Lancet 379(9823):1330
Machado RD, Eickelberg O, Elliott CG et al (2009) Genetics and genomics of pulmonary arterial hypertension. J Am Coll Cardiol 54(1 Suppl):S32–S42. doi:10.1016/j.jacc.2009.04.015
Magnus-Levy A (1914) Ueber ungewohnliche Verkalkung der Arterien. Dtsch Med Wochenschr 40:1305–1309
Marcais C, Verges B, Charriere S et al (2005) Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment. J Clin Invest 115(10):2862–2869. doi:10.1172/JCI24471
Markello TC, Pak LK, St. Hilaire C (2011) Vascular pathology of medial arterial calcifications in NT5E deficiency: implications for the role of adenosine in pseudoxanthoma elasticum. Mol Genet Metab 103(1):44–50. doi:10.1016/j.ymgme.2011.01.018
McAllister KA, Grogg KM, Johnson DW et al (1994) Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 8(4):345–351. doi:10.1038/ng1294-345
McIntyre N (1988) Familial LCAT deficiency and fish-eye disease. J Inherit Metab Dis 11(Suppl 1):45–56
McLean J, Wion K, Drayna D et al (1986) Human lecithin-cholesterol acyltransferase gene: complete gene sequence and sites of expression. Nucleic Acids Res 14(23):9397–9406
Melby SJ, Zierer A, Damiano RJ Jr et al (2013) Importance of blood pressure control after repair of acute type a aortic dissection: 25-year follow-up in 252 patients. J Clin Hypertens (Greenwich) 15(1):63–68. doi:10.1111/jch.12024
Melmon KL, Braunwald E (1963) Familial pulmonary hypertension. N Engl J Med 269:770–775. doi:10.1056/NEJM196310102691502
Menton ML, Fetterman GH (1948) Coronary sclerosis in infancy; report of three autopsied cases, two in siblings. Am J Clin Pathol 18(10):805–810
Merkel M, Loeffler B, Kluger M et al (2005) Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase. J Biol Chem 280(22):21553–21560. doi:10.1074/jbc.M411412200
Milewicz DM, Ostergaard JR, Ala-Kokko LM et al (2010) De novo ACTA2 mutation causes a novel syndrome of multisystemic smooth muscle dysfunction. Am J Med Genet A 152A(10):2437–2443. doi:10.1002/ajmg.a.33657
Mizuguchi T, Collod-Beroud G, Akiyama T et al (2004) Heterozygous TGFBR2 mutations in Marfan syndrome. Nat Genet 36(8):855–860. doi:10.1038/Ng1392
Mohr W, Gorz E (2002) Does arteriosclerotic calcinosis of vessel walls imitate osteogenesis? Pathomorphological studies of arteriosclerotic plaque. Z Kardiol 91(3):212–232
Morano I, Chai GX, Baltas LG et al (2000) Smooth-muscle contraction without smooth-muscle myosin. Nat Cell Biol 2(6):371–375. doi:10.1038/35014065
Morse JH, Jones AC, Barst RJ et al (1997) Mapping of familial primary pulmonary hypertension locus (PPH1) to chromosome 2q31-q32. Circulation 95(12):2603–2606
Motulsky AG (1986) The 1985 Nobel Prize in physiology or medicine. Science 231(4734):126–129
Murphy S, Xu J, Kochanek K (2012) Deaths: preliminary data for 2010. Natl Vital Stat Rep 60(4)
NCEP (2002) Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106(25):3143–3421
Neptune ER, Frischmeyer PA, Arking DE et al (2003) Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nat Genet 33(3):407–411. doi:10.1038/ng1116
Nevin NC, Slack J (1968) Hyperlipidaemic xanthomatosis. II. Mode of inheritance in 55 families with essential hyperlipidaemia and xanthomatosis. J Med Genet 5(1):9–28
Nguyen LB, Shefer S, Salen G et al (1990) A molecular defect in hepatic cholesterol biosynthesis in sitosterolemia with xanthomatosis. J Clin Invest 86(3):923–931. doi:10.1172/JCI114794
Nicolas G, Pottier C, Maltete D et al (2013) Mutation of the PDGFRB gene as a cause of idiopathic basal ganglia calcification. Neurology 80(2):181–187. doi:10.1212/WNL.0b013e31827ccf34
Nitschke Y, Rutsch F (2012) Genetics in arterial calcification: lessons learned from rare diseases. Trends Cardiovasc Med 22(6):145–149. doi:10.1016/j.tcm.2012.07.011
Nitschke Y, Baujat G, Botschen U et al (2012) Generalized arterial calcification of infancy and pseudoxanthoma elasticum can be caused by mutations in either ENPP1 or ABCC6. Am J Hum Genet 90(1):25–39. doi:10.1016/j.ajhg.2011.11.020
Norum KR, Gjone E (1967) Familial serum-cholesterol esterification failure. A new inborn error of metabolism. Biochim Biophys Acta 144(3):698–700
Okawa A, Nakamura I, Goto S et al (1998) Mutation in Npps in a mouse model of ossification of the posterior longitudinal ligament of the spine. Nat Genet 19(3):271–273. doi:10.1038/956
Pannu H, Fadulu VT, Chang J et al (2005) Mutations in transforming growth factor-beta receptor type II cause familial thoracic aortic aneurysms and dissections. Circulation 112(4):513–520. doi:10.1161/CIRCULATIONAHA.105.537340
Pannu H, Tran-Fadulu V, Papke CL et al (2007) MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin II. Hum Mol Genet 16(20):2453–2462. doi:10.1093/hmg/ddm201
Papke CL, Cao J, Kwartler CS et al (2013) Smooth muscle hyperplasia due to loss of smooth muscle alpha-actin is driven by activation of focal adhesion kinase, altered p53 localization and increased levels of platelet-derived growth factor receptor-beta. Hum Mol Genet 22(15):3123–3137. doi:10.1093/hmg/ddt167
Park SO, Lee YJ, Seki T et al (2008) ALK5- and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2. Blood 111(2):633–642. doi:10.1182/blood-2007-08-107359
Patel SB, Salen G, Hidaka H et al (1998) Mapping a gene involved in regulating dietary cholesterol absorption. The sitosterolemia locus is found at chromosome 2p21. J Clin Invest 102(5):1041–1044. doi:10.1172/JCI3963
Pearson GD, Devereux R, Loeys B et al (2008) Report of the National Heart, Lung, and Blood Institute and National Marfan Foundation Working Group on research in Marfan syndrome and related disorders. Circulation 118(7):785–791. doi:10.1161/CIRCULATIONAHA.108.783753
Pejic RN, Lee DT (2006) Hypertriglyceridemia. J Am Board Fam Med 19(3):310–316
Pennacchio LA, Olivier M, Hubacek JA et al (2001) An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 294(5540):169–173. doi:10.1126/science.1064852
Pick L, Pinkus F (1909) Weitere Mitterlung zur Lehre von den Xanthomen. Dermat Wchnschr 49:160–162
Plomp AS, Hu X, de Jong PT et al (2004) Does autosomal dominant pseudoxanthoma elasticum exist? Am J Med Genet A 126A(4):403–412. doi:10.1002/ajmg.a.20632
Pyeritz RE, McKusick VA (1979) The Marfan syndrome: diagnosis and management. N Engl J Med 300(14):772–777. doi:10.1056/NEJM197904053001406
Rader DJ, Daugherty A (2008) Translating molecular discoveries into new therapies for atherosclerosis. Nature 451(7181):904–913. doi:10.1038/nature06796
Rahalkar AR, Giffen F, Har B et al (2009) Novel LPL mutations associated with lipoprotein lipase deficiency: two case reports and a literature review. Can J Physiol Pharmacol 87(3):151–160. doi:10.1139/y09-005
Rall SC Jr, Weisgraber KH, Innerarity TL et al (1982) Structural basis for receptor binding heterogeneity of apolipoprotein E from type III hyperlipoproteinemic subjects. Proc Natl Acad Sci U S A 79(15):4696–4700
Ramjan KA, Roscioli T, Rutsch F et al (2009) Generalized arterial calcification of infancy: treatment with bisphosphonates. Nat Clin Pract Endocrinol Metab 5(3):167–172. doi:ncpendmet1067 [pii] 10.1038/ncpendmet1067
Rees A, Shoulders CC, Stocks J et al (1983) DNA polymorphism adjacent to human apoprotein A-1 gene: relation to hypertriglyceridaemia. Lancet 1(8322):444–446
Regalado ES, Guo DC, Villamizar C et al (2011) Exome sequencing identifies SMAD3 mutations as a cause of familial thoracic aortic aneurysm and dissection with intracranial and other arterial aneurysms. Circ Res 109(6):680–U220. doi:10.1161/Circresaha.111.248161
Rensen SS, Doevendans PA, van Eys GJ (2007) Regulation and characteristics of vascular smooth muscle cell phenotypic diversity. Neth Heart J 15(3):100–108
Repa JJ, Berge KE, Pomajzl C et al (2002) Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta. J Biol Chem 277(21):18793–18800. doi:10.1074/jbc.M109927200
Ringpfeil F, Lebwohl MG, Christiano AM et al (2000) Pseudoxanthoma elasticum: mutations in the MRP6 gene encoding a transmembrane ATP-binding cassette (ABC) transporter. Proc Natl Acad Sci U S A 97(11):6001–6006. doi:10.1073/pnas.100041297
Rust S, Walter M, Funke H et al (1998) Assignment of Tangier disease to chromosome 9q31 by a graphical linkage exclusion strategy. Nat Genet 20(1):96–98. doi:10.1038/1770
Rust S, Rosier M, Funke H et al (1999) Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet 22(4):352–355. doi:10.1038/11921
Rutsch F, Vaingankar S, Johnson K et al (2001) PC-1 nucleoside triphosphate pyrophosphohydrolase deficiency in idiopathic infantile arterial calcification. Am J Pathol 158(2):543–554. doi:10.1016/S0002-9440(10)63996-X
Rutsch F, Ruf N, Vaingankar S et al (2003) Mutations in ENPP1 are associated with ‘idiopathic’ infantile arterial calcification. Nat Genet 34(4):379–381. doi:10.1038/ng1221
Rutsch F, Boyer P, Nitschke Y et al (2008) Hypophosphatemia, hyperphosphaturia, and bisphosphonate treatment are associated with survival beyond infancy in generalized arterial calcification of infancy. Circ Cardiovasc Genet 1(2):133–140. doi:10.1161/CIRCGENETICS.108.797704
Rybczynski M, Mir TS, Sheikhzadeh S et al (2010) Frequency and age-related course of mitral valve dysfunction in the Marfan syndrome. Am J Cardiol 106(7):1048–1053. doi:10.1016/j.amjcard.2010.05.038
Sage AP, Tintut Y, Demer LL (2010) Regulatory mechanisms in vascular calcification. Nat Rev Cardiol 7(9):528–536. doi:10.1038/nrcardio.2010.115
Salaun C, Marechal V, Heard JM (2004) Transport-deficient Pit2 phosphate transporters still modify cell surface oligomers structure in response to inorganic phosphate. J Mol Biol 340(1):39–47. doi:10.1016/j.jmb.2004.04.050
Schermuly RT, Dony E, Ghofrani HA et al (2005) Reversal of experimental pulmonary hypertension by PDGF inhibition. J Clin Invest 115(10):2811–2821. doi:10.1172/JCI24838
Schibler D, Russell RG, Fleisch H (1968) Inhibition by pyrophosphate and polyphosphate of aortic calcification induced by vitamin D3 in rats. Clin Sci 35(2):363–372
Schinke T, Karsenty G (2000) Vascular calcification–a passive process in need of inhibitors. Nephrol Dial Transplant 15(9):1272–1274
Schmierer B, Hill CS (2007) TGFbeta-SMAD signal transduction: molecular specificity and functional flexibility. Nat Rev Mol Cell Biol 8(12):970–982. doi:10.1038/nrm2297
Schmitz G, Langmann T (2001) Structure, function and regulation of the ABC1 gene product. Curr Opin Lipidol 12(2):129–140
Schmitz G, Assmann G, Robenek H et al (1985) Tangier disease: a disorder of intracellular membrane traffic. Proc Natl Acad Sci U S A 82(18):6305–6309
Serfaty-Lacrosniere C, Civeira F, Lanzberg A et al (1994) Homozygous Tangier disease and cardiovascular disease. Atherosclerosis 107(1):85–98
Shanahan CM, Cary NR, Salisbury JR et al (1999) Medial localization of mineralization-regulating proteins in association with Monckeberg’s sclerosis: evidence for smooth muscle cell-mediated vascular calcification. Circulation 100(21):2168–2176
Sharp J (1954) Heredo-familial vascular and articular calcification. Ann Rheum Dis 13(1):15–27
Shen Y, Lookene A, Nilsson S et al (2002) Functional analyses of human apolipoprotein CII by site-directed mutagenesis: identification of residues important for activation of lipoprotein lipase. J Biol Chem 277(6):4334–4342. doi:10.1074/jbc.M105421200
Shepherd J, Packard CJ, Dryburgh FJ et al (1975) Diagnosis of type III hyperlipoproteinemia by chromatography of plasma lipoproteins on columns containing agarose. Clin Chem 21(13):1887–1889
Shovlin CL (1999) Supermodels and disease: insights from the HHT mice. J Clin Invest 104(10):1335–1336. doi:10.1172/JCI8730
Shovlin CL, Hughes JM, Tuddenham EG et al (1994) A gene for hereditary haemorrhagic telangiectasia maps to chromosome 9q3. Nat Genet 6(2):205–209. doi:10.1038/ng0294-205
Shovlin CL, Guttmacher AE, Buscarini E et al (2000) Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 91(1):66–67
Shroff RC, Shanahan CM (2007) The vascular biology of calcification. Semin Dial 20(2):103–109. doi:10.1111/j.1525-139X.2007.00255.x
Simonneau G, Robbins IM, Beghetti M et al (2009) Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 54(1 Suppl):S43–S54. doi:10.1016/j.jacc.2009.04.012
Singaraja RR, Brunham LR, Visscher H et al (2003) Efflux and atherosclerosis: the clinical and biochemical impact of variations in the ABCA1 gene. Arterioscler Thromb Vasc Biol 23(8):1322–1332. doi:10.1161/01.ATV.0000078520.89539.77
Soria LF, Ludwig EH, Clarke HR et al (1989) Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100. Proc Natl Acad Sci USA 86(2):587–591
Speer MY, Yang HY, Brabb T et al (2009) Smooth muscle cells give rise to osteochondrogenic precursors and chondrocytes in calcifying arteries. Circ Res 104(6):733–741. doi:CIRCRESAHA.108.183053 [pii] 10.1161/CIRCRESAHA.108.183053
St. Hilaire C, Ziegler SG, Markello TC (2011) NT5E mutations and arterial calcifications. N Engl J Med 364(5):432–442. doi:10.1056/NEJMoa0912923
Stalenhoef AF (2003) Images in clinical medicine. Phytosterolemia and xanthomatosis. N Engl J Med 349(1):51
Struk B, Neldner KH, Rao VS et al (1997) Mapping of both autosomal recessive and dominant variants of pseudoxanthoma elasticum to chromosome 16p13.1. Hum Mol Genet 6(11):1823–1828
Szabo Z, Varadi A, Li Q et al (2011) ABCC6 does not transport adenosine – relevance to pathomechanism of pseudoxanthoma elasticum. Mol Genet Metab 104(3):421. doi:10.1016/j.ymgme.2011.07.013; author reply 422
Teichert-Kuliszewska K, Kutryk MJ, Kuliszewski MA et al (2006) Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension. Circ Res 98(2):209–217. doi:10.1161/01.RES.0000200180.01710.e6
ten Dijke P, Arthur HM (2007) Extracellular control of TGFbeta signalling in vascular development and disease. Nat Rev Mol Cell Biol 8(11):857–869. doi:10.1038/nrm2262
van de Laar IM, Oldenburg RA, Pals G et al (2011) Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis. Nat Genet 43(2):121–126. doi:10.1038/ng.744
Vaughan CJ, Casey M, He J et al (2001) Identification of a chromosome 11q23.2-q24 locus for familial aortic aneurysm disease, a genetically heterogeneous disorder. Circulation 103(20):2469–2475
Vega GL, Grundy SM (1986) In vivo evidence for reduced binding of low density lipoproteins to receptors as a cause of primary moderate hypercholesterolemia. J Clin Invest 78(5):1410–1414. doi:10.1172/JCI112729
Villa-Bellosta R, Sorribas V (2011) Calcium phosphate deposition with normal phosphate concentration. Role of pyrophosphate. Circ J 75(11):2705–2710
Wang CS, Hartsuck J, McConathy WJ (1992) Structure and functional properties of lipoprotein lipase. Biochim Biophys Acta 1123(1):1–17
Wang X, Sato R, Brown MS et al (1994) SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis. Cell 77(1):53–62
Wang C, Li Y, Shi L et al (2012) Mutations in SLC20A2 link familial idiopathic basal ganglia calcification with phosphate homeostasis. Nat Genet 44(3):254–256. doi:10.1038/ng.1077
Wells IC, Peitzmeier G, Vincent JK (1986) Lecithin: cholesterol acyltransferase and lysolecithin in coronary atherosclerosis. Exp Mol Pathol 45(3):303–310
Weve H (1931) Ueber Arachnodaktylie (Dystrophia mesodermalis congenita, Typus Marfan). Arch f Augenh 104:1–46
Whitfield AJ, Barrett PH, van Bockxmeer FM et al (2004) Lipid disorders and mutations in the APOB gene. Clin Chem 50(10):1725–1732. doi:10.1373/clinchem.2004.038026
Wu M, Rementer C, Giachelli CM (2013) Vascular calcification: an update on mechanisms and challenges in treatment. Calcif Tissue Int 93(4):365–373. doi:10.1007/s00223-013-9712-z
Yamamura T, Sudo H, Ishikawa K et al (1979) Familial type I hyperlipoproteinemia caused by apolipoprotein C-II deficiency. Atherosclerosis 34(1):53–65
Yamashita H, Ichijo H, Grimsby S et al (1994) Endoglin forms a heteromeric complex with the signaling receptors for transforming growth factor-beta. J Biol Chem 269(3):1995–2001
Yang CY, Manoogian D, Pao Q et al (1987) Lecithin:cholesterol acyltransferase. Functional regions and a structural model of the enzyme. J Biol Chem 262(7):3086–3091
Yu L, Li-Hawkins J, Hammer RE et al (2002) Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol. J Clin Invest 110(5):671–680. doi:10.1172/JCI16001
Zannis VI, Just PW, Breslow JL (1981) Human apolipoprotein E isoprotein subclasses are genetically determined. Am J Hum Genet 33(1):11–24
Zhu L, Vranckx R, Khau Van Kien P et al (2006) Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus. Nat Genet 38(3):343–349. doi:10.1038/ng1721
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg (outside the USA)
About this entry
Cite this entry
Boehm, M., Hilaire, C.S. (2015). Vascular Genetics. In: Lanzer, P. (eds) PanVascular Medicine. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-37078-6_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-37078-6_4
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-37077-9
Online ISBN: 978-3-642-37078-6
eBook Packages: MedicineReference Module Medicine